PTC Therapeutics appoints biotech banking veteran Jessica Chutter to board

PTC THERAPEUTICS, INC.

Jessica Chutter appointed to board effective March 24, 2026, as Class I director.
Chutter spent 40+ years at Morgan Stanley, most recently as Managing Director and Chair of Biotech Investment Banking.
She was involved in ~$80B in capital raising and ~$85B in strategic transactions at Morgan Stanley.
Initial director equity grant: 3,475 stock options (36-month monthly vest) and 4,000 RSUs (3-year annual vest).
Also receives pro-rated annual grant: 2,896 stock options and 3,333 RSUs; eligible for future grants per board policy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.